Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease ; volume:11 ; number:1 ; day:10 ; month:8 ; year:2011 ; pages:1-6 ; date:12.2011
BMC neurology ; 11, Heft 1 (10.8.2011), 1-6, 12.2011
- Creator
-
Kim, Han-Joon
- Contributor
-
Jeon, Beom S.
Lee, Won Yong
Lee, Myoung Chong
Kim, Jae Woo
Kim, Jong-min
Ahn, Tae-Beom
Cho, Jinwhan
Chung, Sun Ju
Grieger, Frank
Whitesides, John
Boroojerdi, Babak
SpringerLink (Online service)
- DOI
-
10.1186/1471-2377-11-100
- URN
-
urn:nbn:de:1111-2016030329525
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Han-Joon
- Jeon, Beom S.
- Lee, Won Yong
- Lee, Myoung Chong
- Kim, Jae Woo
- Kim, Jong-min
- Ahn, Tae-Beom
- Cho, Jinwhan
- Chung, Sun Ju
- Grieger, Frank
- Whitesides, John
- Boroojerdi, Babak
- SpringerLink (Online service)
Other Objects (12)
Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
A Conformable Ultrasound Patch for Cavitation‐Enhanced Transdermal Cosmeceutical Delivery
At First Glance: Psoriatic Response to Transdermal Nicotine Patch Application
Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery
Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy
Transdermal electroosmotic flow generated by a porous microneedle array patch
Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain
Transdermal rotigotine for the perioperative management of Parkinson’s disease
Optimization of simvastatin transdermal patch for hyperlipidemia treatment in rat model
Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
A Conformable Ultrasound Patch for Cavitation‐Enhanced Transdermal Cosmeceutical Delivery
At First Glance: Psoriatic Response to Transdermal Nicotine Patch Application
Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery
Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy
Transdermal electroosmotic flow generated by a porous microneedle array patch
Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain
Transdermal rotigotine for the perioperative management of Parkinson’s disease
Optimization of simvastatin transdermal patch for hyperlipidemia treatment in rat model
Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
A Conformable Ultrasound Patch for Cavitation‐Enhanced Transdermal Cosmeceutical Delivery
At First Glance: Psoriatic Response to Transdermal Nicotine Patch Application
Smartphone-powered iontophoresis-microneedle array patch for controlled transdermal delivery
Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy
Transdermal electroosmotic flow generated by a porous microneedle array patch
Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain
Transdermal rotigotine for the perioperative management of Parkinson’s disease